Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

30.82 +0.20 (+0.65%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9 Next >
Puerto Rico Blackout: 8 Stocks Affected By Island-Wide Power Outage
Only around 12% of Puerto Rico's residents currently have electricity, according to Luma Energy, the power company servicing the island. 
Via Benzinga
“Healthcare Left For Dead” Stock Market (And Sentiment Results)
This afternoon felt like either a fund blew up or the margin clerks were taking a bunch of dumb over-leveraged money out to the woodshed to put them out of their misery. 
Via Talk Markets
Topics Stocks / Equities
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Baxter International: Dividend Cut Because Of Restructuring
Baxter International (BAX) cut its dividend because of the upcoming sale of the Kidney Care business, high debt and leverage, lower earnings per share, and free cash flow. 
Via Talk Markets
Topics Stocks / Equities
Uncovering Potential: Baxter Intl's Earnings Preview
Via Benzinga
3 Shareholder Yield Stocks For Growth And Dividends
Top shareholder yield stocks are generating returns by paying dividends, buying back stock, and reducing debt. 
Via Talk Markets
Beyond The Numbers: 6 Analysts Discuss Baxter Intl Stock
Via Benzinga
“Jackets And Packets” Stock Market (And Sentiment Results)
Revenues continue to grow, Free Cash Flow recovering, Margins high, Stock Price subdued. 
Via Talk Markets
Earnings Scheduled For February 13, 2025
Via Benzinga
What To Expect From Baxter’s (BAX) Q4 Earnings
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million
Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Confidence Is Just As Dangerous When It's Too Low As When It's Too High
To attain goals, you need confidence. It takes self-assurance to pursue what matters most to you. But too much confidence has risks, too. 
Via Investor's Business Daily
How Is The Market Feeling About Baxter Intl?
Via Benzinga
The Latest Analyst Ratings For Baxter Intl
Via Benzinga
Baxter Expects Hurricane Helene Aftermath To Impact Near-Term Financial Outlook
Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and improved supply chain management. 
Via Benzinga
Topics Economy
Exposures Supply Chain
US Hospitals Face Critical IV Fluid Shortage After Baxter Facility Shuts Down Due To Hurricane Helene
The U.S. faces a critical shortage of IV fluids due to Hurricane Helene's damage to Baxter's North Carolina plant, forcing hospitals to delay surgeries. Federal efforts to rebuild and import supplies... 
Via Benzinga
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
Baxter International resumes IV fluid shipments from international sites after Hurricane Helene disrupted production at its North Carolina plant, which supplies 60% of U.S. IV fluids. FDA approves... 
Via Benzinga
Exposures Product Safety
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
U.S. Senator Amy Klobuchar has called on HHS Secretary Xavier Becerra to address the national IV solution shortage following the closure of Baxter's facility due to Hurricane Helene, which compromises... 
Via Benzinga
Hurricane Helene Economic Price Tag Could Be $34 Billion; The Stock Market Impact
Moody's Analytics projects major costs. 
Via Investor's Business Daily
Hurricane Helene Shutters Baxter International's Key Manufacturing Hub In North Carolina
Baxter International shuts down its largest manufacturing facility in North Carolina due to Hurricane Helene's damage. Shares fall. 
Via Benzinga
Medtronic Inc. Dividend Stock Analysis - Sunday, Sept. 29
Medtronic Inc. is a global medical device manufacturer with leadership positions in the pacemaker, defibrillator, orthopedic, diabetes management, and other medical markets. Here are some highlights... 
Via Talk Markets
Medtronic Recalls Some Video Laryngoscopes Due To Increased Risk For Battery Overheat, Explosion
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines. 
Via Benzinga
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space. 
Via Investor's Business Daily
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter... 
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare... 
Via Benzinga
3 Contrarian Stock Picks to Buy Against the Market Consensus
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential. 
Via InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.